Skip to main content

Press Releases and Ad-hoc Announcements

22 July 2020
PR: Annual General Meeting 2020 of Heidelberg Pharma Approves All Proposed Resolutions
PDF
21 July 2020
AH: Heidelberg Pharma AG: Main Shareholder dievini Commits to Further Financing for Expansion of Proprietary Pipeline
PDF
09 July 2020
PR: Heidelberg Pharma reports on first half-year 2020
PDF
24 June 2020
PR: Heidelberg Pharma to Present at the Upcoming Virtual European Biotech Investor Day 2020
PDF
27 April 2020
AH: Heidelberg Pharma AG Plans Capital Increase to Fund Its ATAC Development Program
PDF
27 April 2020
AH: Heidelberg Pharma AG Raises EUR 14.4 Million From Private Placement
PDF
23 April 2020
PR: Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2020
PDF
31 March 2020
PR: Heidelberg Pharma AG: European Patent Office Grants Patent for Amatoxin Conjugates for Tumor Therapy
PDF
26 March 2020
PR: Heidelberg Pharma Publishes Article on Chemical Amanitin Synthesis in Angewandte Chemie Journal
PDF
19 March 2020
PR: Heidelberg Pharma Announces Financial Figures for Fiscal Year 2019 and Provides Business Update
PDF
04 March 2020
PR: Heidelberg Pharma AG: US patent rights granted for diagnosis and treatment of patients with TP53/RNA polymerase II deletion
PDF
24 February 2020
PR: Partner Magenta Therapeutics Presents Preclinical Data on Lead Clinical Candidate MGTA-117 Demonstrating Broad Tolerability and High Therapeutic Index
PDF
22 January 2020
AH: Heidelberg Pharma AG Secures Financing Commitment from Its Main Shareholder dievini
PDF
21 November 2019
AH: Heidelberg Pharma Participates in Franco-German Joint Venture Emergence Therapeutics and Signs Collaboration and License Agreement
PDF
12 November 2019
AH: Partner Magenta Therapeutics Exercises Option to Further Develop Antibody Targeted Amanitin Conjugates Targeted to CD45
PDF
07 November 2019
PR: Heidelberg Pharma Announces Participation at Various Conferences
PDF
26 October 2019
PM: Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2019
PDF
11 October 2019
PM: Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2019
PDF
03 October 2019
AH: Heidelberg Pharma AG Announces Adjustment of Guidance
PDF
20 September 2019
PR: Heidelberg Pharma receives European Union research grant for the ETN MAGICBULLET project
PDF
12 July 2019
PR: Heidelberg Pharma reports on first half-year
PDF
12 June 2019
PR: Heidelberg Pharma Presents Proprietary ATAC Technology Platform at Two Scientific Conferences
PDF
06 June 2019
PR: Heidelberg Pharma Receives Milestone Payment from Partner Telix
PDF
22 May 2019
PR: Heidelberg Pharma Reports Outcome Of Annual General Meeting
PDF
12 April 2019
PR: Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2019
PDF
28 March 2019
PR: Heidelberg Pharma to present its proprietary ATAC technology platform at the AACR Annual Meeting 2019
PDF
21 March 2019
PR: Heidelberg Pharma announces financial figures for fiscal year 2018 and provides business update
PDF
23 January 2019
PR: Heidelberg Pharma Receives Milestone Payment From Partner Link Health
PDF
02 November 2018
PM: Heidelberg Pharma Announces Several Presentations of Research Results on ATAC Technology at the ASH Annual Meeting 2018
PDF
11 October 2018
PR: Heidelberg Pharma AG: Interim management statement on the first nine months of 2018
PDF